Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A long-term retrospective comparative study of the oncological outcomes of 598 very young (≤35 years) and young (36-45 years) breast cancer patients.
Szollár A, Újhelyi M, Polgár C, Oláh E, Pukancsik D, Rubovszky G, Udvarhelyi N, Kovács T, Sávolt Á, Kenessey I, Mátrai Z. Szollár A, et al. Among authors: rubovszky g. Eur J Surg Oncol. 2019 Nov;45(11):2009-2015. doi: 10.1016/j.ejso.2019.06.007. Epub 2019 Jun 5. Eur J Surg Oncol. 2019. PMID: 31189512
[Triple-negative breast carcinoma--rewiev of current literature].
Rubovszky G, Udvarhelyi N, Horváth Z, Láng I, Kásler M. Rubovszky G, et al. Magy Onkol. 2010 Dec;54(4):325-35. doi: 10.1556/MOnkol.54.2010.4.6. Magy Onkol. 2010. PMID: 21163763 Free article. Review. Hungarian.
Promising novel targeted chemotherapeutic agents include PARP1 inhibitors, a new group of compounds exploiting the defective DNA repair machinery. Rubovszky G, Udvarhelyi N, Horvath Z, Lang I, Kasler M. Triple negative breast carcinoma - rewiev of current literature …
Promising novel targeted chemotherapeutic agents include PARP1 inhibitors, a new group of compounds exploiting the defective DNA repair mach …
[Modern pharmacological therapy of breast cancer].
Láng I, Kahán Z, Hitre E, Dank M, Rubovszky G, Horváth Z, Kásler M. Láng I, et al. Among authors: rubovszky g. Orv Hetil. 2012 Jan 15;153(2):56-65. doi: 10.1556/OH.2012.29257. Orv Hetil. 2012. PMID: 22217685 Review. Hungarian.
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G. Sávolt A, et al. Among authors: rubovszky g. Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765. Orv Hetil. 2013. PMID: 24292111 Clinical Trial. Hungarian.
[Special aspects of breast cancer surgery in the elderly].
Mátrai Z, Polgár C, Kovács E, Bartal A, Rubovszky G, Gulyás G. Mátrai Z, et al. Among authors: rubovszky g. Orv Hetil. 2014 Jun 15;155(24):931-8. doi: 10.1556/OH.2014.29889. Orv Hetil. 2014. PMID: 24918175 Review. Hungarian.
[Breast cancer care quality analysis of the National Institute of Oncology in Hungary according to the requirements of European Society of Breast Cancer Specialists (EUSOMA)].
Újhelyi M, Pukancsik D, Kelemen P, Sávolt Á, Gődény M, Kovács E, Udvarhelyi N, Bak M, Polgár C, Rubovszky G, Kásler M, Mátrai Z. Újhelyi M, et al. Among authors: rubovszky g. Orv Hetil. 2016 Oct;157(42):1674-1682. doi: 10.1556/650.2016.30555. Orv Hetil. 2016. PMID: 27748131 Hungarian.
Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, Győrffy B, Kásler M, Mátrai Z. Sávolt Á, et al. Among authors: rubovszky g. Eur J Surg Oncol. 2017 Apr;43(4):672-679. doi: 10.1016/j.ejso.2016.12.011. Epub 2017 Jan 16. Eur J Surg Oncol. 2017. PMID: 28139362 Clinical Trial.
Evaluation of the central pedicled, modified Wise-pattern technique as a standard level II oncoplastic breast-conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients.
Kelemen P, Pukancsik D, Újhelyi M, Kovács E, Stamatiou A, Ivády G, Kenessey I, Kovács T, Smanykó V, Rubovszky G, Mátrai Z. Kelemen P, et al. Among authors: rubovszky g. Breast J. 2019 Sep;25(5):922-926. doi: 10.1111/tbj.13371. Epub 2019 Jun 4. Breast J. 2019. PMID: 31165547
56 results